Lilly to Sell Zepbound Through Telehealth Platform Ro

Seeking Alpha10minutes ago

Hims & Hers Health, Inc. Falls 7% as Ro Says It Is Working With Eli Lilly to Streamline Access to Zepbound

Investing08:22 ET

Ro Partners With Eli Lilly to Enhance Obesity Treatment Access; Hims & Hers Health Shares Fall

Investing08:20 ET

Hims & Hers Health Options Spot-On: On December 10th, 88,818 Contracts Were Traded, With 573.71K Open Interest

Moomoo News16:30 ET

CCORF Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $38

Moomoo NewsDec 6 07:31 ET · Ratings

Hims & Hers Health: Buy Rating Backed by Promising Growth in GLP-1 Market and Strong Telehealth Positioning

TipRanksDec 6 07:28 ET · Ratings